Počet záznamov: 1
antihistaminiká H1, bez sedatívneho účinku
SYS d039563 LBL 00000cz--a2200000n--4500 005 20250606214241.4 008 020702|||anznnbabn-----------|-a|a------ 040 $b slo $a DNLM $d BA006 $d BA006 $a BA006 $d BA006 $d BA006 065 $a D27.505.519.625.375.425.400.500 065 $a D27.505.696.577.375.425.400.500 066 $a 01 $c 03 150 $a antihistaminiká H1, bez sedatívneho účinku $x AD $x AE $x AN $x BL $x CF $x CH $x CL $x CS $x EC $x HI $x IM $x IP $x ME $x PD $x PK $x PO $x RE $x SD $x ST $x TO $x TU $x UR $2 slo 450 $w v $a Second Generation Antihistamine $2 eng 450 $w v $a Second Generation H1 Antagonist $2 eng 450 $w v $a Third Generation H1 Antagonist $2 eng 450 $w v $a antihistaminiká druhej generácie $2 slo 450 $w v $a antagonisty histamínu H1, nesedatívne $2 slo 450 $w v $a antagonisty histamínu H1, bez sedatívneho účinku $2 slo 450 $w v $a antihistaminiká H1 druhej generácie $2 slo 450 $w v $a antihistaminiká H1 tretej generácie $2 slo 550 $7 sllk_us_auth*d018926 $Y Anti-Allergic Agents $w p $a antialergiká 665 $a 2003 $2 eng 665 $a Benzhydryl Compounds (1982-2002) $2 eng 665 $a Histamine H1 Antagonists (1982-2002) $2 eng 680 9-
$i A class of non-sedating drugs that bind to but do not activate histamine receptors (DRUG INVERSE AGONISM), thereby blocking the actions of histamine or histamine agonists. These antihistamines represent a heterogenous group of compounds with differing chemical structures, adverse effects, distribution, and metabolism. Compared to the early (first generation) antihistamines, these non-sedating antihistamines have greater receptor specificity, lower penetration of BLOOD-BRAIN BARRIER, and are less likely to cause drowsiness or psychomotor impairment. $2 eng 750 -2
$a Histamine H1 Antagonists, Non-Sedating $2 eng 980 $x M
Počet záznamov: 1